118 related articles for article (PubMed ID: 15495942)
21. [Cervical cancer in Frederiksborg County 1990-1991].
Ingeholm P; Glenthøj A
Ugeskr Laeger; 1996 Feb; 158(7):915-8. PubMed ID: 8638329
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening: A Slovenian experience.
Primic-Zakelj M; Repse-Fokter A
Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
24. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
25. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening.
Plaxe SC; Saltzstein SL
Gynecol Oncol; 1999 Oct; 75(1):55-61. PubMed ID: 10502426
[TBL] [Abstract][Full Text] [Related]
26. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
27. A screening programme for cervical cancer that worked.
Hakama M; Louhivuori K
Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
[TBL] [Abstract][Full Text] [Related]
28. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
29. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
Case AS; Rocconi RP; Straughn JM; Wang W; Roark K; Waltman EE; Huh WK
Obstet Gynecol; 2006 Dec; 108(6):1369-74. PubMed ID: 17138768
[TBL] [Abstract][Full Text] [Related]
30. Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.
Casamitjana M; Sala M; Ochoa D; Fusté P; Castells X; Alameda F;
Eur J Public Health; 2009 Oct; 19(5):499-503. PubMed ID: 19435798
[TBL] [Abstract][Full Text] [Related]
31. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
32. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of cervical screening - expectation and reality].
Kostova P; Zlatkov V
Akush Ginekol (Sofiia); 2000; 39(3):23-4. PubMed ID: 11187989
[TBL] [Abstract][Full Text] [Related]
34. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
[TBL] [Abstract][Full Text] [Related]
35. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
van der Horst J; Siebers AG; Bulten J; Massuger LF; de Kok IM
Cancer Med; 2017 Feb; 6(2):416-423. PubMed ID: 28102052
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological data on cervical carcinoma relevant to cytopathology.
La Vecchia C; Decarli A; Gallus G
Appl Pathol; 1987; 5(1):25-32. PubMed ID: 3620205
[TBL] [Abstract][Full Text] [Related]
37. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
Klinkhamer PJ; van der Graaf Y; Vooijs GP
Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
[No Abstract] [Full Text] [Related]
38. [Population screening for cervix carcinoma in the city of Rotterdam, 1st round].
van der Lee-Bijlsma A
Ned Tijdschr Geneeskd; 1981 Dec; 125(49):2012-5. PubMed ID: 7322220
[No Abstract] [Full Text] [Related]
39. [Studies on the appropriated interval of mass screening for cervical cancer].
Kusanagi T; Kudo R; Ito E; Sagae S; Hori Y; Tamura H; Hayakawa O; Fujimura Y; Hashimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):782-6. PubMed ID: 6875333
[TBL] [Abstract][Full Text] [Related]
40. [Studies on factors influencing unfavorably the results of radiotherapy of the cervix uteri cancer in the 1st degree of clinical advancement].
Swiatkowska H
Rozpr Wydz Nauk Med; 1967; 12(2):69-102. PubMed ID: 5594704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
